NL8400098A - Resinaat van een gesubstitueerd carbonzuur, werkwijzen ter bereiding ervan, de toepassing ervan en deze verbindingen bevattende farmaceutische preparaten. - Google Patents

Resinaat van een gesubstitueerd carbonzuur, werkwijzen ter bereiding ervan, de toepassing ervan en deze verbindingen bevattende farmaceutische preparaten. Download PDF

Info

Publication number
NL8400098A
NL8400098A NL8400098A NL8400098A NL8400098A NL 8400098 A NL8400098 A NL 8400098A NL 8400098 A NL8400098 A NL 8400098A NL 8400098 A NL8400098 A NL 8400098A NL 8400098 A NL8400098 A NL 8400098A
Authority
NL
Netherlands
Prior art keywords
formula
resinate
resin
active substance
pharmaceutical preparations
Prior art date
Application number
NL8400098A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NL8400098A publication Critical patent/NL8400098A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8400098A 1983-01-12 1984-01-11 Resinaat van een gesubstitueerd carbonzuur, werkwijzen ter bereiding ervan, de toepassing ervan en deze verbindingen bevattende farmaceutische preparaten. NL8400098A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH14783 1983-01-12
CH14783A CH655507B (hu) 1983-01-12 1983-01-12

Publications (1)

Publication Number Publication Date
NL8400098A true NL8400098A (nl) 1984-08-01

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8400098A NL8400098A (nl) 1983-01-12 1984-01-11 Resinaat van een gesubstitueerd carbonzuur, werkwijzen ter bereiding ervan, de toepassing ervan en deze verbindingen bevattende farmaceutische preparaten.

Country Status (41)

Country Link
US (1) US4510128A (hu)
EP (1) EP0122219B1 (hu)
JP (1) JPS59134759A (hu)
KR (1) KR900006747B1 (hu)
AR (1) AR240310A1 (hu)
AT (2) AT391467B (hu)
AU (1) AU570230B2 (hu)
BE (1) BE898649A (hu)
CA (1) CA1218077A (hu)
CH (1) CH655507B (hu)
CS (1) CS269954B2 (hu)
DD (1) DD218373A5 (hu)
DE (2) DE3474152D1 (hu)
DK (1) DK166683B1 (hu)
DZ (1) DZ593A1 (hu)
EG (1) EG16562A (hu)
ES (1) ES8504849A1 (hu)
FI (1) FI82682C (hu)
FR (1) FR2542735B1 (hu)
GB (1) GB2134529B (hu)
GR (1) GR79793B (hu)
HK (1) HK90390A (hu)
HU (1) HU190750B (hu)
IE (1) IE56545B1 (hu)
IL (1) IL70660A (hu)
IT (1) IT1177501B (hu)
LU (1) LU85171A1 (hu)
MA (1) MA20000A1 (hu)
MC (1) MC1564A1 (hu)
MT (1) MTP943B (hu)
NL (1) NL8400098A (hu)
NO (1) NO162862C (hu)
NZ (1) NZ206815A (hu)
OA (1) OA07628A (hu)
PH (1) PH21795A (hu)
PL (1) PL142737B1 (hu)
PT (1) PT77932B (hu)
RO (1) RO88481A (hu)
SE (1) SE457959B (hu)
ZA (1) ZA84212B (hu)
ZW (1) ZW484A1 (hu)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
CH675537A5 (hu) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
AU2259692A (en) * 1991-07-03 1993-02-11 Sano Corporation Composition and method for transdermal delivery of diclofenac
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
DE60232290D1 (de) * 2001-04-09 2009-06-25 Rohm & Haas Kontrollierte Auflösung von Wirkstoffen
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
US20080095842A1 (en) * 2004-12-06 2008-04-24 Antarkar Amit K Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
EP2428205B1 (en) * 2006-03-16 2012-10-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US7799347B2 (en) 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
JP5670336B2 (ja) * 2008-10-02 2015-02-18 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 全身性炎症の治療のためのポリマー吸着剤の投与
WO2011119839A1 (en) 2010-03-24 2011-09-29 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
KR20210094513A (ko) 2018-11-19 2021-07-29 재즈 파마슈티칼즈 아일랜드 리미티드 알코올-내성 약물 제형
BR112021013766A2 (pt) 2019-03-01 2021-09-21 Flamel Ireland Limited Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
NL6817965A (hu) * 1967-12-20 1969-06-24
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
DD218373A5 (de) 1985-02-06
MC1564A1 (fr) 1984-11-12
ATA784A (de) 1990-04-15
EG16562A (en) 1991-12-30
IL70660A (en) 1987-08-31
CS269954B2 (en) 1990-05-14
MTP943B (en) 1984-06-05
DK11884A (da) 1984-07-13
DK166683B1 (da) 1993-06-28
US4510128A (en) 1985-04-09
IT8447527A0 (it) 1984-01-10
KR840007562A (ko) 1984-12-08
AT391467B (de) 1990-10-10
PT77932A (en) 1984-02-01
CS17884A2 (en) 1989-10-13
DZ593A1 (fr) 2004-09-13
BE898649A (fr) 1984-07-11
FI840069A0 (fi) 1984-01-09
JPS59134759A (ja) 1984-08-02
AU570230B2 (en) 1988-03-10
GR79793B (hu) 1984-10-31
DE3400491C2 (hu) 1988-11-10
HU190750B (en) 1986-10-28
OA07628A (fr) 1985-05-23
ZA84212B (en) 1984-08-29
PT77932B (en) 1986-07-22
ES528770A0 (es) 1985-05-01
GB2134529B (en) 1986-09-24
LU85171A1 (de) 1984-10-24
DE3400491A1 (de) 1984-07-12
NO162862B (no) 1989-11-20
PH21795A (en) 1988-02-29
EP0122219A3 (en) 1985-05-08
IE840049L (en) 1984-07-12
ATE37378T1 (de) 1988-10-15
GB8400251D0 (en) 1984-02-08
ES8504849A1 (es) 1985-05-01
SE8400098L (sv) 1984-07-13
DE3474152D1 (en) 1988-10-27
SE8400098D0 (sv) 1984-01-10
FI82682C (fi) 1991-04-10
IL70660A0 (en) 1984-04-30
CA1218077A (en) 1987-02-17
IE56545B1 (en) 1991-08-28
AU2323084A (en) 1984-07-19
PL142737B1 (en) 1987-11-30
ZW484A1 (en) 1984-08-08
HK90390A (en) 1990-11-09
EP0122219B1 (de) 1988-09-21
FI82682B (fi) 1990-12-31
CH655507B (hu) 1986-04-30
JPH0257058B2 (hu) 1990-12-03
DK11884D0 (da) 1984-01-11
GB2134529A (en) 1984-08-15
IT1177501B (it) 1987-08-26
HUT34151A (en) 1985-02-28
FR2542735A1 (fr) 1984-09-21
NO840090L (no) 1984-07-13
FR2542735B1 (fr) 1986-04-18
SE457959B (sv) 1989-02-13
FI840069A (fi) 1984-07-13
NZ206815A (en) 1986-08-08
AR240310A1 (es) 1990-03-30
RO88481A (ro) 1986-01-30
KR900006747B1 (ko) 1990-09-20
EP0122219A2 (de) 1984-10-17
MA20000A1 (fr) 1984-10-01
PL245656A1 (en) 1985-01-02
NO162862C (no) 1990-02-28

Similar Documents

Publication Publication Date Title
NL8400098A (nl) Resinaat van een gesubstitueerd carbonzuur, werkwijzen ter bereiding ervan, de toepassing ervan en deze verbindingen bevattende farmaceutische preparaten.
US20230248676A1 (en) Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US4814354A (en) Lipid regulating agents
EP0368682B1 (en) Pharmaceutical ion exchange resin composition
JP2688541B2 (ja) 消化管治療のための製品及び方法
US4938967A (en) Pharmaceutical formulations
US4847077A (en) Controlled release pharmaceutical preparations
DD298049A5 (de) Doppelt beschichtete granulate
KR20000067929A (ko) 고인혈증 치료제
NO852880L (no) Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering
NO140526B (no) Vernevisiranording for sikkerhetshjelm
JPS60139620A (ja) 高血圧症の治療、抗高血圧及び利尿のための化合物及び組成物
DE69733752T2 (de) Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
NL8802224A (nl) Orale magnesium en kalium bevattende preparaten.
US6004546A (en) Pharmaceutical composition containing bismuth-polyacrylic acid compounds
EP0159735A1 (en) Pharmaceutical composition containing tetracyclin or doxycyclin salts and a process of preparing such a composition
WO1999056738A1 (en) Use of triclosan for the treatment of helicobacter pylori infections
US2811492A (en) Polyamine sulfonic acid type adsorption compound
US3709989A (en) Composition and method for treatment of ossilets and pathological calcification in animals
US3842169A (en) Composition and method for treatment of pathological calcification in animals
JPH09278657A (ja) 制酸剤の使用方法および制酸剤を配合した製剤
JPS589083B2 (ja) シヨウリユウザイノセイゾウホウ
JPH0225414A (ja) 持続性経口剤
JPH06157306A (ja) ペニシライド系化合物を有効成分とする脂質低下剤
BE897402A (nl) Preparaat voor de bereiding van een oraal toe te dienen rehydraterende oplossing voor dieren

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed